Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
R. R. Donnelley & Sons Company is a specialty business services business based in the US. RRDonnelley-and-Sons Company shares (RRD) are listed on the NYSE and all prices are listed in US Dollars. RRDonnelley-and-Sons Company employs 33,000 staff and has a trailing 12-month revenue of around USD$4.8 billion.
|52-week range||USD$0.72 - USD$4.7|
|50-day moving average||USD$2.6662|
|200-day moving average||USD$1.7957|
|Wall St. target price||USD$6|
|Dividend yield||USD$0.03 (0.77%)|
|Earnings per share (TTM)||USD$1.358|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing RRDonnelley-and-Sons Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of RRDonnelley-and-Sons Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
RRDonnelley-and-Sons Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 3x. In other words, RRDonnelley-and-Sons Company shares trade at around 3x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
RRDonnelley-and-Sons Company's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.33. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into RRDonnelley-and-Sons Company's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
RRDonnelley-and-Sons Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$345.6 million.
The EBITDA is a measure of a RRDonnelley-and-Sons Company's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$4.8 billion|
|Operating margin TTM||4.65%|
|Gross profit TTM||USD$977.1 million|
|Return on assets TTM||4.28%|
|Return on equity TTM||0%|
|Market capitalisation||USD$322.8 million|
TTM: trailing 12 months
There are currently 1.1 million RRDonnelley-and-Sons Company shares held short by investors – that's known as RRDonnelley-and-Sons Company's "short interest". This figure is 34.1% down from 1.7 million last month.
There are a few different ways that this level of interest in shorting RRDonnelley-and-Sons Company shares can be evaluated.
RRDonnelley-and-Sons Company's "short interest ratio" (SIR) is the quantity of RRDonnelley-and-Sons Company shares currently shorted divided by the average quantity of RRDonnelley-and-Sons Company shares traded daily (recently around 688627.04402516). RRDonnelley-and-Sons Company's SIR currently stands at 1.59. In other words for every 100,000 RRDonnelley-and-Sons Company shares traded daily on the market, roughly 1590 shares are currently held short.
However RRDonnelley-and-Sons Company's short interest can also be evaluated against the total number of RRDonnelley-and-Sons Company shares, or, against the total number of tradable RRDonnelley-and-Sons Company shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case RRDonnelley-and-Sons Company's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 RRDonnelley-and-Sons Company shares in existence, roughly 20 shares are currently held short) or 0.0188% of the tradable shares (for every 100,000 tradable RRDonnelley-and-Sons Company shares, roughly 19 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against RRDonnelley-and-Sons Company.
Find out more about how you can short RRDonnelley-and-Sons Company stock.
We're not expecting RRDonnelley-and-Sons Company to pay a dividend over the next 12 months.
RRDonnelley-and-Sons Company's shares were split on a 1:3 basis on 3 October 2016. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your RRDonnelley-and-Sons Company shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for RRDonnelley-and-Sons Company shares which in turn could have impacted RRDonnelley-and-Sons Company's share price.
Over the last 12 months, RRDonnelley-and-Sons Company's shares have ranged in value from as little as $0.72 up to $4.7. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while RRDonnelley-and-Sons Company's is 2.849. This would suggest that RRDonnelley-and-Sons Company's shares are significantly more volatile than the average for this exchange and represent a higher risk.
R.R. Donnelley & Sons Company, an integrated communications provider, enables organizations to create, manage, deliver, and optimize their multichannel marketing and business communications. Its Business Services segment offers commercial printing products and branded materials, including manuals, publications, brochures, business cards, flyers, post cards, posters, and promotional items; and packaging solutions comprising rigid boxes and in-box print materials for clients in the consumer electronics, healthcare and life sciences, cosmetics, and consumer packaged goods industries. It also provides customer billings, financial statements, healthcare communications, and insurance document statement printing services; and distribution, shipping, healthcare, durable goods, promotional, and consumer product goods packaging labels. In addition, this segment offers workflow design, assembly, configuration, kitting, and fulfillment services for clients in the consumer electronics, telecommunications, life sciences, cosmetics, education, and industrial industries. Further, it provides invoices, order, and business forms that support the private and public sectors; and outsourcing services, such as creative services, research and analytics, financial management, and other services for legal providers, insurance, telecommunications, utilities, retail, and financial services companies. The company's Marketing Solutions segment offers direct marketing, such as audience segmentation, creative development, program testing, print production, postal optimization, and performance analytics for large-scale personalized direct mail programs; and in-store marketing, digital print, kitting, fulfillment, digital, and creative solutions and list services. It operates in the United States, Asia, Europe, and internationally. The company was founded in 1864 and is headquartered in Chicago, Illinois.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Everything we know about the ChargePoint IPO, plus information on how to buy in.
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
Everything we know about the Soho House IPO, plus information on how to buy in.
Everything we know about the VIZIO IPO, plus information on how to buy in.
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.